Utah Medical Products Current Ratio 2012-2025 | UTMD
Utah Medical Products current ratio from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Utah Medical Products Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $0.10B | $0.00B | 32.06 |
| 2025-06-30 | $0.09B | $0.00B | 41.87 |
| 2025-03-31 | $0.10B | $0.00B | 22.29 |
| 2024-12-31 | $0.10B | $0.00B | 25.64 |
| 2024-09-30 | $0.10B | $0.00B | 29.59 |
| 2024-06-30 | $0.10B | $0.00B | 25.98 |
| 2024-03-31 | $0.11B | $0.01B | 19.57 |
| 2023-12-31 | $0.11B | $0.01B | 22.56 |
| 2023-09-30 | $0.10B | $0.00B | 24.38 |
| 2023-06-30 | $0.10B | $0.01B | 19.21 |
| 2023-03-31 | $0.10B | $0.01B | 15.66 |
| 2022-12-31 | $0.09B | $0.01B | 15.09 |
| 2022-09-30 | $0.08B | $0.01B | 13.44 |
| 2022-06-30 | $0.08B | $0.00B | 17.79 |
| 2022-03-31 | $0.08B | $0.01B | 13.03 |
| 2021-12-31 | $0.07B | $0.00B | 19.54 |
| 2021-09-30 | $0.08B | $0.01B | 15.12 |
| 2021-06-30 | $0.07B | $0.00B | 15.93 |
| 2021-03-31 | $0.07B | $0.01B | 14.59 |
| 2020-12-31 | $0.06B | $0.00B | 16.42 |
| 2020-09-30 | $0.06B | $0.00B | 15.79 |
| 2020-06-30 | $0.05B | $0.00B | 16.38 |
| 2020-03-31 | $0.05B | $0.00B | 13.48 |
| 2019-12-31 | $0.06B | $0.00B | 15.92 |
| 2019-09-30 | $0.05B | $0.00B | 13.43 |
| 2019-06-30 | $0.05B | $0.00B | 12.10 |
| 2019-03-31 | $0.05B | $0.01B | 6.48 |
| 2018-12-31 | $0.06B | $0.01B | 11.58 |
| 2018-09-30 | $0.06B | $0.01B | 12.38 |
| 2018-06-30 | $0.06B | $0.01B | 10.67 |
| 2018-03-31 | $0.05B | $0.01B | 10.38 |
| 2017-12-31 | $0.05B | $0.01B | 9.32 |
| 2017-09-30 | $0.05B | $0.01B | 9.27 |
| 2017-06-30 | $0.04B | $0.00B | 9.97 |
| 2017-03-31 | $0.04B | $0.01B | 7.55 |
| 2016-12-31 | $0.03B | $0.00B | 11.41 |
| 2016-09-30 | $0.04B | $0.01B | 7.58 |
| 2016-06-30 | $0.04B | $0.01B | 7.57 |
| 2016-03-31 | $0.04B | $0.01B | 6.04 |
| 2015-12-31 | $0.03B | $0.00B | 8.09 |
| 2015-09-30 | $0.03B | $0.01B | 5.63 |
| 2015-06-30 | $0.03B | $0.01B | 5.62 |
| 2015-03-31 | $0.03B | $0.01B | 5.00 |
| 2014-12-31 | $0.03B | $0.01B | 3.31 |
| 2014-09-30 | $0.03B | $0.01B | 3.12 |
| 2014-06-30 | $0.03B | $0.01B | 3.10 |
| 2014-03-31 | $0.03B | $0.01B | 3.08 |
| 2013-12-31 | $0.02B | $0.01B | 3.19 |
| 2013-09-30 | $0.03B | $0.01B | 2.66 |
| 2013-06-30 | $0.02B | $0.01B | 2.59 |
| 2013-03-31 | $0.02B | $0.01B | 2.39 |
| 2012-12-31 | $0.02B | $0.01B | 2.37 |
| 2012-09-30 | $0.02B | $0.01B | 1.76 |
| 2012-06-30 | $0.02B | $0.01B | 1.74 |
| 2012-03-31 | $0.02B | $0.01B | 1.69 |
| 2011-12-31 | $0.02B | $0.01B | 1.77 |
| 2011-09-30 | $0.02B | $0.01B | 1.69 |
| 2011-06-30 | $0.02B | $0.01B | 1.71 |
| 2011-03-31 | $0.02B | $0.01B | 1.60 |
| 2010-12-31 | $0.03B | $0.00B | 13.21 |
| 2010-09-30 | $0.03B | $0.00B | 10.54 |
| 2010-06-30 | $0.03B | $0.00B | 11.56 |
| 2010-03-31 | $0.03B | $0.00B | 8.78 |
| 2009-12-31 | $0.03B | $0.00B | 14.90 |
| 2009-09-30 | $0.03B | $0.00B | 8.84 |
| 2009-06-30 | $0.03B | $0.00B | 10.55 |
| 2009-03-31 | $0.03B | $0.00B | 7.35 |
| 2008-12-31 | $0.02B | $0.00B | 13.17 |
| 2008-09-30 | $0.03B | $0.00B | 9.61 |
| 2008-06-30 | $0.03B | $0.00B | 9.86 |
| 2008-03-31 | $0.03B | $0.00B | 8.18 |
| 2007-12-31 | $0.03B | $0.00B | 9.46 |
| 2007-09-30 | $0.03B | $0.00B | 8.41 |
| 2007-06-30 | $0.03B | $0.00B | 8.94 |
| 2007-03-31 | $0.03B | $0.00B | 6.98 |
| 2006-12-31 | $0.03B | $0.00B | 8.40 |
| 2006-09-30 | $0.03B | $0.00B | 8.56 |
| 2006-06-30 | $0.03B | $0.00B | 9.65 |
| 2006-03-31 | $0.03B | $0.00B | 9.26 |
| 2005-12-31 | $0.03B | $0.00B | 7.13 |
| 2005-09-30 | $0.02B | $0.00B | 6.65 |
| 2005-06-30 | $0.02B | $0.00B | 7.74 |
| 2005-03-31 | $0.02B | $0.00B | 6.34 |
| 2004-12-31 | $0.03B | $0.00B | 5.66 |
| 2004-09-30 | $0.03B | $0.00B | 6.45 |
| 2004-06-30 | $0.03B | $0.01B | 6.20 |
| 2004-03-31 | $0.03B | $0.01B | 4.21 |
| 2003-12-31 | $0.03B | $0.01B | 2.71 |
| 2003-09-30 | $0.01B | $0.00B | 4.71 |
| 2003-06-30 | $0.01B | $0.00B | 4.54 |
| 2003-03-31 | $0.01B | $0.00B | 2.93 |
| 2002-12-31 | $0.01B | $0.00B | 3.35 |
| 2002-09-30 | $0.01B | $0.00B | 4.32 |
| 2002-06-30 | $0.01B | $0.00B | 3.90 |
| 2002-03-31 | $0.01B | $0.00B | 2.85 |
| 2001-12-31 | $0.01B | $0.00B | 3.18 |
| 2001-09-30 | $0.01B | $0.00B | 3.06 |
| 2001-06-30 | $0.01B | $0.00B | 3.37 |
| 2001-03-31 | $0.01B | $0.00B | 2.60 |
| 2000-12-31 | $0.01B | $0.00B | 3.05 |
| 2000-09-30 | $0.01B | $0.00B | 3.30 |
| 2000-06-30 | $0.01B | $0.00B | 3.61 |
| 2000-03-31 | $0.01B | $0.00B | 3.21 |
| 1999-12-31 | $0.01B | $0.00B | 3.21 |
| 1999-09-30 | $0.01B | $0.00B | 3.79 |
| 1999-06-30 | $0.01B | $0.00B | 4.62 |
| 1999-03-31 | $0.01B | $0.00B | 3.49 |
| 1998-12-31 | $0.01B | $0.00B | 4.37 |
| 1998-09-30 | $0.01B | $0.00B | 4.68 |
| 1998-06-30 | $0.01B | $0.01B | 2.18 |
| 1998-03-31 | $0.01B | $0.01B | 1.70 |
| 1997-12-31 | $0.01B | $0.00B | 4.35 |
| 1997-09-30 | $0.01B | $0.00B | 3.65 |
| 1997-06-30 | $0.01B | $0.01B | 2.45 |
| 1997-03-31 | $0.01B | $0.00B | 1.64 |
| 1996-12-31 | $0.02B | $0.00B | 3.67 |
| 1996-09-30 | $0.02B | $0.00B | 4.28 |
| 1996-06-30 | $0.00B | 0.00 | |
| 1996-03-31 | $0.03B | $0.01B | 5.52 |
| 1995-12-31 | $0.02B | $0.00B | 6.43 |
| 1995-09-30 | $0.02B | $0.00B | 6.25 |
| 1995-06-30 | $0.02B | $0.00B | 6.36 |
| 1995-03-31 | $0.02B | $0.00B | 5.60 |
| 1994-12-31 | $0.02B | $0.00B | 5.36 |
| 1994-09-30 | $0.02B | $0.00B | 6.46 |
| 1994-06-30 | $0.02B | $0.00B | 5.38 |
| 1994-03-31 | $0.02B | $0.00B | 5.95 |
| 1993-12-31 | $0.02B | $0.00B | 7.08 |
| 1993-09-30 | $0.02B | $0.00B | 7.15 |
| 1993-06-30 | $0.02B | $0.00B | 8.23 |
| 1993-03-31 | $0.02B | $0.00B | 6.41 |
| 1992-12-31 | $0.02B | $0.00B | 7.73 |
| 1992-09-30 | $0.02B | $0.00B | 5.51 |
| 1992-06-30 | $0.02B | $0.00B | 4.76 |
| 1992-03-31 | $0.02B | $0.00B | 3.71 |
| 1991-12-31 | $0.02B | $0.00B | 3.91 |
| 1991-09-30 | $0.01B | $0.00B | 3.58 |
| 1991-06-30 | $0.01B | $0.00B | 3.85 |
| 1991-03-31 | $0.01B | $0.00B | 3.35 |
| 1990-12-31 | $0.01B | $0.00B | 3.39 |
| 1990-09-30 | $0.01B | $0.00B | 3.43 |
| 1990-06-30 | $0.01B | $0.00B | 2.92 |
| 1990-03-31 | $0.01B | $0.00B | 2.33 |
| 1989-12-31 | $0.01B | $0.00B | 2.18 |
| 1989-09-30 | $0.01B | $0.00B | 1.80 |
| 1989-06-30 | $0.01B | $0.00B | 2.57 |
| 1989-03-31 | $0.01B | $0.00B | 2.99 |
| 1988-12-31 | $0.01B | $0.00B | 2.75 |
| 1988-09-30 | $0.01B | $0.00B | 3.72 |
| 1988-06-30 | $0.01B | $0.00B | 3.57 |
| 1988-03-31 | $0.01B | $0.00B | 3.70 |
| 1987-12-31 | $0.01B | $0.00B | 4.11 |
| 1987-09-30 | $0.00B | $0.00B | 1.50 |
| 1987-06-30 | $0.00B | $0.00B | 1.39 |
| 1987-03-31 | $0.00B | $0.00B | 1.39 |
| 1986-12-31 | $0.00B | $0.00B | 1.39 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.198B | $0.039B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $190.250B | 21.25 |
| EssilorLuxottica (ESLOY) | France | $141.053B | 0.00 |
| Stryker (SYK) | United States | $140.785B | 27.01 |
| Boston Scientific (BSX) | United States | $136.192B | 31.14 |
| Medtronic (MDT) | Ireland | $131.676B | 18.24 |
| Medline (MDLN) | United States | $59.144B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.791B | 0.00 |
| Agilent Technologies (A) | United States | $38.383B | 24.26 |
| ResMed (RMD) | United States | $37.110B | 24.78 |
| GE HealthCare Technologies (GEHC) | United States | $36.492B | 17.45 |
| Koninklijke Philips (PHG) | Netherlands | $27.828B | 18.18 |
| Terumo (TRUMY) | Japan | $19.515B | 22.05 |
| Insulet (PODD) | United States | $18.052B | 56.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.087B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.556B | 0.00 |
| Baxter (BAX) | United States | $10.214B | 8.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.023B | 28.85 |
| Demant (WILYY) | Denmark | $7.483B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.410B | 13.43 |
| Envista Holdings (NVST) | United States | $3.825B | 21.94 |
| BillionToOne (BLLN) | United States | $3.824B | 0.00 |
| ICU Medical (ICUI) | United States | $3.739B | 23.74 |
| Prestige Consumer Healthcare (PBH) | United States | $3.147B | 14.35 |
| Haemonetics (HAE) | United States | $3.079B | 13.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.007B | 0.00 |
| Neogen (NEOG) | United States | $2.230B | 48.81 |
| Perrigo (PRGO) | Ireland | $1.971B | 4.94 |
| LeMaitre Vascular (LMAT) | United States | $1.960B | 39.45 |
| QuidelOrtho (QDEL) | United States | $1.878B | 12.07 |
| AtriCure (ATRC) | United States | $1.831B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.699B | 16.97 |
| Curaleaf Holdings (CURLF) | Canada | $1.472B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.459B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.394B | 61.09 |
| AdaptHealth (AHCO) | United States | $1.368B | 19.80 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.159B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.075B | 319.00 |
| Capricor Therapeutics (CAPR) | United States | $1.056B | 0.00 |
| InMode (INMD) | Israel | $1.051B | 11.87 |
| Tilray Brands (TLRY) | Canada | $0.867B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.862B | 0.00 |
| Omeros (OMER) | United States | $0.831B | 0.00 |
| Valneva SE (VALN) | France | $0.788B | 0.00 |
| CeriBell (CBLL) | United States | $0.750B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.594B | 16.09 |
| Brainsway (BWAY) | Israel | $0.455B | 77.50 |
| Verano Holdings (VRNO) | United States | $0.450B | 0.00 |
| Cerus (CERS) | United States | $0.446B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.372B | 0.00 |
| Evolus (EOLS) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.304B | 24.24 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.255B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.228B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.222B | 130.67 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.199B | 0.00 |
| High Tide (HITI) | Canada | $0.198B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.196B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.176B | 1.76 |
| Apyx Medical (APYX) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.77 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.109B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.54 |
| Exagen (XGN) | United States | $0.087B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 23.50 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Nephros (NEPH) | United States | $0.049B | 35.15 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 17.86 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Flora Growth (ZSTK) | United States | $0.008B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |